/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $72M · -77.07% margin · $107M FCF
The business is unprofitable at the operating level (-148.63% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 4174.5% YoY with margins expanding 7369.8pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$72M
▲ +4174.5% YoY
Net Income (TTM)
-$36M
▲ +31.9% YoY
Op. Margin
-77.07%
▲ +7369.8pp YoY
ROIC
-10.85%
▲ +15.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$107M
▲ +257.6% YoY
Op. Cash Flow (TTM)
$108M
▲ +263.3% YoY
Net Debt
-$324M
Net Cash Position
Cash & Equiv.
$347M
Continue Research